Nisin antibacterial peptide: AMBI began a Phase I double-blind, placebo-controlled study in healthy volunteers.

Applied Microbiology Inc. (AMBI), Tarrytown, N.Y. Product: Nisin antibacterial peptide Indication: Ulcers associated with H. pylori infection Status: AMBI began a Phase I double-blind, placebo-control...